|
|
Post by #NoMoreNeedles on Oct 24, 2017 16:48:55 GMT -5
Why?
|
|
|
|
Post by uvula on Oct 24, 2017 16:49:56 GMT -5
Because Merck already has a CMO?
|
|
|
|
Post by kc on Oct 24, 2017 17:00:19 GMT -5
I thought that everybody already knew that answer.  |
|
|
|
Post by lennymnkd on Oct 24, 2017 17:04:32 GMT -5
š
|
|
|
|
Post by lennymnkd on Oct 24, 2017 17:06:25 GMT -5
Help ! Do I give sophie a thumbs up ? Iām confused .
|
|
|
|
Post by rockstarrick on Oct 24, 2017 20:52:48 GMT -5
|
|
|
|
Post by tiberious on Oct 24, 2017 20:56:04 GMT -5
Anders went to Sandbagofi after RIF in MKC Paramus and never updated his profile.
|
|
|
|
Post by golfeveryday on Oct 24, 2017 21:16:10 GMT -5
he has another profile that appears to be much more up to date. His other profile has him presently working for both MNKD & SNY. |
|
|
|
Post by kc on Oct 24, 2017 21:31:39 GMT -5
Looks like he is still at Sanofi.
|
|
|
|
Post by rockstarrick on Oct 24, 2017 22:20:44 GMT -5
Looks like he is still at Sanofi. And mnkd ?? Who knows š |
|
|
|
Post by ghochr on Oct 24, 2017 22:28:07 GMT -5
Amazing that folks here not realizing that executive level positions are never advertised even if the position is vacant. There is usually a separate channel for executive positions. š¤¦āāļø
|
|
|
|
Post by itellthefuture777 on Oct 26, 2017 9:43:53 GMT -5
Looks like some Sanofi sales folks..stayed or switched over to MNKD...thats pretty interesting...leaving a giant Sanofi..and going to Mannkind...Sales guy must be happy with the new label..lets see what he does with it..
|
|
|
|
Post by casualinvestor on Oct 26, 2017 9:52:22 GMT -5
The smart ones are probably moving for the MNKD stock options/bonuses....compared to the same from SNY  *Disclaimer...I know nothing about pharma repping or compensation |
|
